GO:0004053 arginase activity: Mechanism, Genes

Arginase activity (GO:0004053) is a molecular function that catalyzes the hydrolysis of L-arginine to L-ornithine and urea. This reaction is central to nitrogen metabolism and to the regulation of arginine bioavailability, which in turn influences diverse biological processes including immune cell function, vascular biology, and tissue repair. Because arginine is a substrate for both nitric oxide synthases and arginases, the balance between these pathways determines whether arginine is used for nitric oxide production or for polyamine and proline synthesis via ornithine. Consequently, arginase activity is a key node in immunometabolism and has been implicated in conditions ranging from cancer to allergic inflammation. In the immune system, arginase activity in myeloid cells can deplete extracellular L-arginine, leading to reduced T cell proliferation and cytokine production, a mechanism of reversible T cell hyporesponsiveness. Neutrophil granulocytes can also express ARG1, and inhibition of ARG1 liberates their T cell immunostimulatory activity. In pregnancy, arginase activity contributes to maternal immune tolerance by mediating T cell hyporesponsiveness. Beyond immunity, arginase activity is involved in glomerulonephritis, where it may influence renal injury and remodeling, and in allergic airway inflammation, where ARG1-mediated arginine metabolism in eosinophils is linked to lysosomal acidity and cathepsin L activity. For researchers, GO:0004053 provides a precise functional annotation for studies of arginine metabolism, immune regulation, and disease mechanisms. Experimental determination of arginase activity is well established, typically by measuring urea or L-ornithine formation from L-arginine. The availability of CRISPR tools to knock out, mutate, or overexpress ARG1 and ARG2 enables rigorous testing of causal roles in cellular and animal models. This article summarizes the definition, mechanisms, key genes, disease links, and research methods for arginase activity, with all factual claims supported by the cited literature.

Arginase activity (GO:0004053) is defined as the catalysis of the reaction: L-arginine + H2O = L-ornithine + urea. In other words, it is the enzymatic function that splits the amino acid L-arginine into L-ornithine and urea through hydrolysis. This activity is encoded by arginase enzymes, principally ARG1 and ARG2 in mammals, and is a key step in the urea cycle and in arginine catabolism.

Arginase activity is important because it controls the availability of L-arginine, a semi-essential amino acid that is critical for immune cell proliferation and function, nitric oxide synthesis, and polyamine production. By converting L-arginine to L-ornithine and urea, arginases can suppress T cell responses and shape the tumor microenvironment, making them attractive targets in immuno-oncology. In allergic airway inflammation, ARG1-mediated arginine metabolism in eosinophils is linked to lysosomal acidity and cathepsin L activation, highlighting a role beyond classical urea cycle biology. Arginase activity also contributes to renal pathology in glomerulonephritis and to maternal immune tolerance during pregnancy. Thus, understanding and measuring arginase activity is essential for basic immunology, metabolic research, and therapeutic development.

The following genes and proteins are directly associated with arginase activity (GO:0004053) and its regulation in mammalian systems.

Arginase activity is regulated at multiple levels. Substrate availability of L-arginine, transport via cationic amino acid transporters, and competition with nitric oxide synthases influence flux through the arginase reaction. Cytokines such as IL-4 and IL-13 can induce ARG1 expression in myeloid cells, while inflammatory signals modulate ARG2. Endogenous inhibitors including L-ornithine and branched-chain amino acids can feedback on arginase activity. In pregnancy, arginase activity mediates reversible T cell hyporesponsiveness, indicating hormonal and immune regulation. In neutrophils, ARG1 inhibition enhances T cell stimulation, suggesting that arginase activity is actively restrained in some contexts. Exercise-induced histone lactylation in monocyte-derived macrophages has been linked to cardiac immune homeostasis in sepsis, highlighting systemic regulation of arginine metabolism.

Arginase activity contributes to tumor immune evasion by depleting L-arginine and suppressing T cell responses. Inhibition of arginase activity with thymoquinone induces a hybrid type of cell death in MDA-MB-231 breast cancer cells, demonstrating that targeting this activity can directly affect cancer cell viability. ARG1 expression in myeloid cells is associated with poor antitumor immunity, making arginase a candidate target for immunotherapy.

In allergic airway inflammation, ARG1-mediated arginine metabolism in eosinophils is linked to lysosomal acidity and cathepsin L activation, which promotes eosinophil activation. This implicates arginase activity in the pathogenesis of asthma and allergic diseases. Targeting ARG1 may therefore modulate eosinophilic inflammation.

Arginase activity has been implicated in glomerulonephritis, where it may influence renal injury and remodeling. The balance between arginase and nitric oxide synthase pathways affects glomerular hemodynamics and inflammation. Experimental models of glomerulonephritis can be used to study arginase modulation.

Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy, contributing to maternal immune tolerance of the fetus. This highlights a physiological role for arginase in immune regulation beyond disease. Understanding this mechanism may inform reproductive immunology and transplantation tolerance.

Arginase activity is commonly measured by incubating cell or tissue lysates with L-arginine and quantifying the production of urea or L-ornithine. Colorimetric and radiometric assays are available, and the method can be adapted to mammalian samples. This direct enzymatic measurement is the gold standard for confirming GO:0004053 activity.

RNA-seq and quantitative PCR can measure ARG1 and ARG2 transcript levels, while Western blotting and proteomics can quantify protein abundance. These methods help link arginase activity to transcriptional and post-transcriptional regulation. Immunohistochemistry can localize ARG1 in tissues.

Mass spectrometry-based metabolomics can measure L-arginine, L-ornithine, and urea levels to infer arginase pathway flux. Stable isotope tracing with labeled arginine can quantify conversion to ornithine and downstream metabolites. These approaches provide systems-level insight into arginine metabolism.

CRISPR knockout screens can identify genes that regulate arginase activity or arginine dependence in cancer and immune cells. Pooled screens targeting metabolic enzymes can reveal synthetic lethal interactions with arginase inhibition. Bioinformatics analysis of screen data helps prioritize candidate pathways.

Researchers studying arginase activity-related genes often need to determine whether a candidate gene is causally involved in arginine metabolism, immune regulation, or disease. EDITGENE provides CRISPR-based cell model services to enable such causal studies with high precision and reproducibility.

Arginase activity (GO:0004053) is a fundamental molecular function that hydrolyzes L-arginine to L-ornithine and urea, with far-reaching consequences for nitrogen metabolism, immune regulation, and disease. Its dysregulation is linked to cancer, allergic inflammation, renal disease, and pregnancy-associated immune tolerance. Advances in CRISPR-based models and biochemical assays now allow precise interrogation of arginase activity in diverse biological contexts. Continued research on this activity will likely yield new therapeutic strategies targeting arginine metabolism.